CVM Competitors & Alternatives
Compare Cel-Sci Corporation with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CVM
Main Stock$4.32
Tradestie Score
52
Market Cap
$68.41M
Revenue Growth
-0.6%
Analyst Upside
+478.7%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$342.57
|
$160.70B | 24.5 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$140.13
|
$137.92B | 20.6 | 59 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$748.25
|
$46.96B | 38.2 | 55 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.28
|
$24.57B | - | 59 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$172.34
|
$22.61B | 20.2 | 55 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$132.48
|
$13.59B | 28.2 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$43.98
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$48.77
|
$10.74B | - | 62 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.78
|
$10.04B | 20.1 | 65 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.80
|
$9.33B | 100.2 | 56 | Compare |
More CVM Analysis
Data updated: Apr 06, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry